Cross-Trial Evidence & HTA Operations Søborg or Aalborg (DK), Onsite, or United Kingdom or Spain, Virtual For people living with serious chronic diseases, an approved medicine is only as good as the access they have to it. In market after market, HTA bodies, reimbursement authorities and payers must